Oorsprong van het eerstegraads netwerk van Wulff-Erik von Borcke
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 23 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wulff-Erik von Borcke via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Compliance Officer | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| PULSE BIOSCIENCES, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| Hamilton College (New York) | College/University | Undergraduate Degree | |
| Cedar Crest College | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
| Georgia State University | College/University | Masters Business Admin | |
| Kansas State University | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Graduate Degree | |
| University of California, Santa Cruz | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Masters Business Admin | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
Robert W. Duggan & Associates
 Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Investment Managers | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
| Lymphoma Research Foundation | Director/Board Member | ||
Healogix LLC
 Healogix LLC Miscellaneous Commercial ServicesCommercial Services Healogix LLC is a healthcare marketing research and consulting firm. The private company is based in Horsham, PA. The company was founded by Harris Kaplan. Harris Kaplan has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| DERMIRA, INC. | Pharmaceuticals: Major | General Counsel | |
| Berlex Laboratories, Inc. | Corporate Officer/Principal | ||
| Seton Hall University School of Law | College/University | Graduate Degree | |
| Pennsylvania State University College of Medicine | College/University | Doctorate Degree | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| SUMMIT THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal | |
| BIOMEA FUSION, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Moores Cancer Center | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Verenigd Koninkrijk | 2 |
| Zweden | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 35 |
| Consumer Services | 12 |
| Finance | 2 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 56 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 26 |
| Chief Tech/Sci/R&D Officer | 15 |
| Undergraduate Degree | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Robert Duggan | 18 |
| Diane Parks | 14 |
| Mahkam Zanganeh | 14 |
| Manmeet Singh Soni | 13 |
| Ramses Erdtmann | 13 |
| Elizabeth Faust | 12 |
| Dawn Bir | 8 |
| Kenneth Clark | 7 |
| Dakota Gallivan | 7 |
| Raymond Jeffrey Kmetz | 6 |
| Kristi Miller | 5 |
| Matthew Outten | 5 |
| John Northcott | 5 |
| Danelle James | 5 |
- Beurs
- Insiders
- Wulff-Erik von Borcke
- Bedrijfsconnecties